《Chinese Journal of Rehabilitation Theory and Practice》 ›› 2017, Vol. 23 ›› Issue (4): 433-437.doi: 10.3969/j.issn.1006-9771.2017.04.015

• CONTENTS • Previous Articles     Next Articles

Clinical Characteristics and Efficacy Analysis of Children with Cerebral Palsy and Neuronal Migration Disorders 

ZHAO Yong, JIN Bing-xu, LIU Zhen-huan   

  1. Department of Children Nerve Rehabilitation of Nanhai Maternity and Kid Hospital, Guangzhou University of TCM, Foshan, Guangdong 528200, China
  • Received:2016-12-30 Published:2017-04-05 Online:2017-05-17
  • Contact: ZHAO Yong. E-mail: tcmdoctor@163.com

Abstract: Objective To discuss the clinical characteristics and efficacy analysis of children with cerebral palsy and neuronal migration disorders (NMD) by retrospective analysis. Methods From June, 2005 to June, 2015, 32 children with cerebral palsy and NMD were enrolled as NMD group, while 60 children with cerebral palsy with periventricular leukomalacia (PVL) as PVL group. Both groups received comprehensive rehabilitation for three months. Their clinical classification, complications of epilepsy or epileptiform discharges, the score of Gross Motor Function Measure (GMFM), and development quotient (DQ) were compared, as well as the follow-up results of six months. Results There was significant difference in the clinical classification of cerebral palsy between two groups (χ2=24.529, P<0.001). The incidence of epilepsy and epileptiform discharges was higher in NMD group than in PVL group (χ2>4.605, P<0.05). After treatment, the score of GMFM improved with time in both groups (Ftime=6.850, P=0.010), and was significantly lower in NMD group than in GMFM group (Fgroup=29.885, P<0.001); the scores of DQ in all the functional areas improved with time in both groups (Ftime>25.041, P<0.001), and were significantly lower in NMD group than in GMFM group (Fgroup >32.347, P<0.001). Conclusion Children with cerebral palsy and NMD are characterized by mental retardation, epilepsy and spastic hemiplegia, and poor outcome.

Key words: cerebral palsy, neuronal migration disorders, periventricular leukomalacia, clinical characteristics, efficacy analysis

CLC Number: